Psilocybin’s therapeutic benefits have been recognized by the medical industry too. The Johns Hopkins Center for Psychedelic and Consciousness Research has invested in a psychedelic and psilocybin therapy and research center, thanks to $17 million in funding, so that researchers can learn more about psychedelics, how they can help treat illness, and develop new treatments for behavioral disorders.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…